Michael J. LaRiviere

982 total citations
51 papers, 504 citations indexed

About

Michael J. LaRiviere is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Michael J. LaRiviere has authored 51 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Michael J. LaRiviere's work include CAR-T cell therapy research (14 papers), Lymphoma Diagnosis and Treatment (8 papers) and Cutaneous lymphoproliferative disorders research (5 papers). Michael J. LaRiviere is often cited by papers focused on CAR-T cell therapy research (14 papers), Lymphoma Diagnosis and Treatment (8 papers) and Cutaneous lymphoproliferative disorders research (5 papers). Michael J. LaRiviere collaborates with scholars based in United States, Greece and Senegal. Michael J. LaRiviere's co-authors include Robert E. Gross, Patricia Mae G. Santos, James M. Metz, Christine E. Hill‐Kayser, Erica L. Carpenter, John P. Plastaras, Bakhtiar Yamini, Taylor A. Black, Stephanie S. Yee and Elise A. Chong and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Michael J. LaRiviere

45 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael J. LaRiviere United States	10	174	122	98	92	84	51	504
Timon Hussain Germany	16	187 1.1×	201 1.6×	62 0.6×	147 1.6×	101 1.2×	45	1.0k
Esteban Velarde United States	12	630 3.6×	121 1.0×	65 0.7×	114 1.2×	230 2.7×	29	991
Eva‐Maria Weiss Germany	13	303 1.7×	223 1.8×	43 0.4×	106 1.2×	130 1.5×	22	828
Y. Watson United Kingdom	12	145 0.8×	152 1.2×	48 0.5×	304 3.3×	72 0.9×	23	678
Navid Redjal United States	13	196 1.1×	140 1.1×	50 0.5×	35 0.4×	94 1.1×	35	656
Brittany Voth United States	13	59 0.3×	107 0.9×	51 0.5×	33 0.4×	57 0.7×	29	508
Zhiping Zhou United States	12	201 1.2×	141 1.2×	44 0.4×	116 1.3×	73 0.9×	28	671
Henry Ruiz-García United States	14	112 0.6×	89 0.7×	61 0.6×	59 0.6×	162 1.9×	38	552
Jonatan Snir Canada	10	129 0.7×	156 1.3×	48 0.5×	181 2.0×	135 1.6×	22	653
Alissa A. Thomas United States	11	139 0.8×	97 0.8×	64 0.7×	40 0.4×	66 0.8×	35	514

Countries citing papers authored by Michael J. LaRiviere

Since Specialization

Citations

This map shows the geographic impact of Michael J. LaRiviere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. LaRiviere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. LaRiviere more than expected).

Fields of papers citing papers by Michael J. LaRiviere

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. LaRiviere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. LaRiviere. The network helps show where Michael J. LaRiviere may publish in the future.

Co-authorship network of co-authors of Michael J. LaRiviere

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. LaRiviere. A scholar is included among the top collaborators of Michael J. LaRiviere based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. LaRiviere. Michael J. LaRiviere is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wada, David A., Mei Wei, Shane Lloyd, et al.. (2025). Mental Health Diagnoses in Patients With Mycosis Fungoides and Potential Impact on Oncologic Outcomes. Cancer Medicine. 14(5). e70577–e70577. 1 indexed citations

Sussman, Jonathan, Colin Thomas, Daniel J. Landsburg, et al.. (2025). Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome. JAMA Dermatology. 161(6). 656–656.

Hubbeling, Harper, Kang Yu, Michael J. LaRiviere, et al.. (2025). Outcomes of radiation integrated with T-cell–engaging bispecific antibodies in relapsed/refractory multiple myeloma. Blood Advances. 10(4). 1395–1399.

Beghi, Silvia, Denisa Goia, Renzo Perales‐Linares, et al.. (2024). Local radiation enhances systemic CAR T-cell efficacy by augmenting antigen crosspresentation and T-cell infiltration. Blood Advances. 8(24). 6308–6320. 7 indexed citations

Kim, Michele M., Xiaoyan Han, Monica Chelius, et al.. (2024). Outcomes of proton therapy to infradiaphragmatic sites in pediatric patients with Hodgkin lymphoma. Pediatric Blood & Cancer. 71(12). e31290–e31290. 2 indexed citations

Svoboda, Jakub, Daniel J. Landsburg, Sunita D. Nasta, et al.. (2024). Safety and efficacy of armored huCART19-IL18 in patients with relapsed/refractory lymphomas that progressed after anti-CD19 CAR T cells.. Journal of Clinical Oncology. 42(16_suppl). 7004–7004. 11 indexed citations

Yegya‐Raman, Nikhil, Christopher M. Wright, Michael J. LaRiviere, et al.. (2023). Salvage radiotherapy for relapsed/refractory non‐Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy. Clinical and Translational Radiation Oncology. 39. 100587–100587. 4 indexed citations

Kim, Kristine, Michael Salerno, Payal D. Shah, Jennifer M. Matro, & Michael J. LaRiviere. (2022). Severe acute radiation dermatitis after palbociclib therapy in the setting of palliative radiotherapy. Journal of Oncology Pharmacy Practice. 29(3). 764–767. 1 indexed citations

Kim, Kristine, et al.. (2022). Life-threatening altered mental status secondary to memantine in an adolescent undergoing cranial radiotherapy for medulloblastoma. Journal of Oncology Pharmacy Practice. 29(2). 469–472. 1 indexed citations

10.

LaRiviere, Michael J., Yash Shah, Abigail Doucette, et al.. (2022). General Anesthesia for Pediatric Radiation Therapy in the Era of COVID-19. Advances in Radiation Oncology. 7(4). 100929–100929. 1 indexed citations

11.

Wright, Christopher M., Jonathan Baron, Elise A. Chong, et al.. (2021). Palliative Radiotherapy for Diffuse Large B-cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 21(10). 650–658. 7 indexed citations

12.

Yousefi, Bardia, Michael J. LaRiviere, Eric A. Cohen, et al.. (2021). Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitors. Scientific Reports. 11(1). 9984–9984. 24 indexed citations

13.

Yang, Zijian, Michael J. LaRiviere, Jina Ko, et al.. (2020). A Multianalyte Panel Consisting of Extracellular Vesicle miRNAs and mRNAs, cfDNA, and CA19-9 Shows Utility for Diagnosis and Staging of Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 26(13). 3248–3258. 87 indexed citations

14.

Wright, Christopher M., Michael J. LaRiviere, Jonathan Baron, et al.. (2020). Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell Lymphoma. International Journal of Radiation Oncology*Biology*Physics. 108(1). 178–188. 65 indexed citations

15.

LaRiviere, Michael J., Robert A. Avery, J. Gregory Dolan, et al.. (2019). Emergent Radiation for Leukemic Optic Nerve Infiltration in a Child Receiving Intrathecal Methotrexate. Practical Radiation Oncology. 9(4). 226–230. 1 indexed citations

16.

Aggarwal, Charu, Jeffrey C. Thompson, Austin L. Chien, et al.. (2019). MA25.04 Blood-Based Tumor Mutation Burden as a Predictive Biomarker for Outcomes After Pembrolizumab Based First Line Therapy in Metastatic NSCLC. Journal of Thoracic Oncology. 14(10). S352–S352. 4 indexed citations

17.

LaRiviere, Michael J., Naomi B. Haas, Brad Foulk, et al.. (2019). Prediction of metastatic castrate-resistant prostate cancer response to abiraterone or enzalutamide by a baseline blood-based CTC gene expression signature.. Journal of Clinical Oncology. 37(15_suppl). e16529–e16529. 1 indexed citations

18.

LaRiviere, Michael J., et al.. (2019). CAR-T Cell Therapy for Lymphoma: How Does Radiation Therapy Fit In?. Practical Radiation Oncology. 10(3). e155–e158. 7 indexed citations

19.

LaRiviere, Michael J. & Robert E. Gross. (2016). Stereotactic Laser Ablation for Medically Intractable Epilepsy: The Next Generation of Minimally Invasive Epilepsy Surgery. Frontiers in Surgery. 3. 64–64. 62 indexed citations

20.

Wu, Chengyuan, Michael J. LaRiviere, Nealen G. Laxpati, et al.. (2014). Extraventricular Long-Axis Cannulation of the Hippocampus. Operative Neurosurgery. 10(2). 325–333. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact